JP2002268097A5 - - Google Patents

Download PDF

Info

Publication number
JP2002268097A5
JP2002268097A5 JP2001070371A JP2001070371A JP2002268097A5 JP 2002268097 A5 JP2002268097 A5 JP 2002268097A5 JP 2001070371 A JP2001070371 A JP 2001070371A JP 2001070371 A JP2001070371 A JP 2001070371A JP 2002268097 A5 JP2002268097 A5 JP 2002268097A5
Authority
JP
Japan
Prior art keywords
ring
group
display device
organic compound
electrophoretic display
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001070371A
Other languages
Japanese (ja)
Other versions
JP4048721B2 (en
JP2002268097A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2001070371A priority Critical patent/JP4048721B2/en
Priority claimed from JP2001070371A external-priority patent/JP4048721B2/en
Priority to US10/097,361 priority patent/US6650463B2/en
Publication of JP2002268097A publication Critical patent/JP2002268097A/en
Publication of JP2002268097A5 publication Critical patent/JP2002268097A5/ja
Application granted granted Critical
Publication of JP4048721B2 publication Critical patent/JP4048721B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (3)

電気泳動粒子を分散させる分散媒中に、構造式中に環を含む有機化合物が含まれていることを特徴とする電気泳動表示装置。An electrophoretic display device comprising an organic compound containing a ring in a structural formula in a dispersion medium in which electrophoretic particles are dispersed. 前記有機化合物は、下記の(1)〜(4)のいずれかの構造式で表される一つまたは二つ以上の混合物であり、
前記有機化合物の分散媒中の含有率は30体積%以上であることを特徴とする請求項1記載の電気泳動表示装置。
【化1】
式中、A1〜A6は、ベンゼン環、シクロヘキサン環、ジオキサン環、ピリミジン環、フラン環、テトラヒドロフラン環、ジチアン環、ピペリジン環、ピレラジン環、モーホリン環、シクロペンタン環、シクロブタン環、ピリジン環、チオフェン環、ピロール環、またはシクロヘキセン環であり、
X1〜X4,Y1〜Y3,Zは、1個または複数個の置換基(水素、フッ素、塩素、臭素、ヨウ素、シアノ基、ニトロ基、アミノ基、ヒドロキシル基、アルカノイルオキシ基、アルコキシカルボニル基、カルボキシ基、トリフルオロメチル基、トリフルオロメトキシ基、アルコキシメチレン基、アルキル基、アルコキシ基、アルケニル基、アルキニル基、スルホン酸基、チオアルキル基、モノ、ジ、またはトリアルキルアミノ基)を示し、
B1〜B4は、なし(環同士の単結合)か、COO、OCO、CH=N、N=CH、CH=CH、(CH2)n O、O(CH2)n 、(CH2)n 、O(CH2)n O、CH=CH−COO、OCO−CH=CH、O、CO、NHCO、CONH、N=N、N2 O、C≡C、SO、SO2 、またはNHを示し(nは1〜10の整数)、
C1,C2は、ナフタレン、テトラヒドロナフタレン、デカヒドロナフタレン、インデン、キノリン、クマリン、アズレン、フルオレン、ジヒドロフェナントレンを示す。
The organic compound is one or a mixture of two or more represented by any one of the following structural formulas (1) to (4):
The electrophoretic display device according to claim 1, wherein the content of the organic compound in the dispersion medium is 30% by volume or more.
[Chemical 1]
In the formula, A1 to A6 are benzene ring, cyclohexane ring, dioxane ring, pyrimidine ring, furan ring, tetrahydrofuran ring, dithiane ring, piperidine ring, pyrerazine ring, morpholine ring, cyclopentane ring, cyclobutane ring, pyridine ring, thiophene ring. , A pyrrole ring, or a cyclohexene ring,
X1-X4, Y1-Y3, Z are one or more substituents (hydrogen, fluorine, chlorine, bromine, iodine, cyano group, nitro group, amino group, hydroxyl group, alkanoyloxy group, alkoxycarbonyl group, Carboxy group, trifluoromethyl group, trifluoromethoxy group, alkoxymethylene group, alkyl group, alkoxy group, alkenyl group, alkynyl group, sulfonic acid group, thioalkyl group, mono, di, or trialkylamino group)
B1~B4 either without (single bond rings), COO, OCO, CH = N, N = CH, CH = CH, (CH 2) n O, O (CH 2) n, (CH 2) n , O (CH 2 ) n O, CH═CH—COO, OCO—CH═CH, O, CO, NHCO, CONH, N═N, N 2 O, C≡C, SO, SO 2 , or NH (N is an integer from 1 to 10),
C1, C2 represents naphthalene, tetrahydronaphthalene, decahydronaphthalene, indene, quinoline, coumarin, azulene, fluorene, dihydrophenanthrene.
電極間の領域を画素毎にセルで区分し、各セルの内部でのみ電気泳動粒子の移動を許容するようにしてある請求項1または2記載の電気泳動表示装置。The electrophoretic display device according to claim 1 or 2, wherein a region between the electrodes is divided into cells for each pixel, and movement of the electrophoretic particles is allowed only within each cell.
JP2001070371A 2001-03-13 2001-03-13 Dispersion medium Expired - Fee Related JP4048721B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2001070371A JP4048721B2 (en) 2001-03-13 2001-03-13 Dispersion medium
US10/097,361 US6650463B2 (en) 2001-03-13 2002-03-12 Electrophoretic display device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001070371A JP4048721B2 (en) 2001-03-13 2001-03-13 Dispersion medium

Publications (3)

Publication Number Publication Date
JP2002268097A JP2002268097A (en) 2002-09-18
JP2002268097A5 true JP2002268097A5 (en) 2005-03-03
JP4048721B2 JP4048721B2 (en) 2008-02-20

Family

ID=18928256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001070371A Expired - Fee Related JP4048721B2 (en) 2001-03-13 2001-03-13 Dispersion medium

Country Status (1)

Country Link
JP (1) JP4048721B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2637884A1 (en) * 2006-02-13 2007-08-23 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders

Similar Documents

Publication Publication Date Title
Li et al. Novel ionic liquid-type Gemini surfactants: Synthesis, surface property and antimicrobial activity
TWI522391B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
Dong et al. Self-aggregation behavior of fluorescent carbazole-tailed imidazolium ionic liquids in aqueous solutions
Bodenant et al. Metal-induced self-assembly of a pyrene-tethered hydroxamate ligand for the generation of multichromophoric supramolecular systems. The pyrene excimer as switch for iron (III)-driven intramolecular fluorescence quenching
CN105683829B (en) Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal indicate element
BR0211472A (en) New compounds
DK1421074T3 (en) New connections
CA2359810A1 (en) Process for the preparation of pure citalopram
IL177291A0 (en) Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
EP1813270A4 (en) Hsp90 family protein inhibitors
PT87683B (en) PREPARATION PROCESS OF FURANONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN101766973A (en) Symmetric cationic surfactant and preparation method thereof
CN102775325B (en) Pyrene symmetric disk-like compound and preparation method thereof
JP2007504133A5 (en)
JP2002268097A5 (en)
EP2968232A1 (en) Histone deacetylase inhibitors and compositions and methods of use thereof
EP1215203B1 (en) Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
JP2002268098A5 (en)
CN111690947A (en) Electrochemical synthesis method of trifluoromethylated aryl amide derivative
EP1731519A4 (en) Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same
Cushman et al. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors
CN106431998B (en) N [4 (different Korean pine amide groups) phenyl] aromatic sulfuryl amine class compound and preparation method thereof and active anticancer application
Chemam et al. Recent advances in the chemistry of chlorosulfonyl isocyanate: a review
WO2002038530A8 (en) Carboxylic acid type lipid
Endo et al. Polymethylcarborane as a novel bioactive moiety: derivatives with potent retinoid antagonistic activity